Literature DB >> 12832520

Identification of a novel, membrane-associated neuronal kinase, cyclin-dependent kinase 5/p35-regulated kinase.

Sashi Kesavapany1, Kwok-Fai Lau, Steven Ackerley, Steven J Banner, Stephen J A Shemilt, Jonathan D Cooper, P Nigel Leigh, Christopher E Shaw, Declan M McLoughlin, Christopher C J Miller.   

Abstract

Here we characterize a novel neuronal kinase, cyclin-dependent kinase 5 (cdk5)/p35-regulated kinase (cprk). Cprk is a member of a previously undescribed family of kinases that are predicted to contain two N-terminal membrane-spanning domains and a long C terminus, which harbors a dual-specificity serine/threonine/tyrosine kinase domain. Cprk was isolated in a yeast two-hybrid screen using the neuronal cdk5 activator p35 as "bait." Cprk interacts with p35 in the yeast-two hybrid system, binds to p35 in glutathione S-transferase fusion pull-down assays, and colocalizes with p35 in cultured neurons and transfected cells. In these cells, cprk is present with p35 in the Golgi apparatus. Cprk is expressed in a number of tissues but is enriched in brain and muscle and within the brain is found in a wide range of neuronal populations. Cprk displays catalytic activity in in vitro kinase assays and is itself phosphorylated by cdk5/p35. Cdk5/p35 inhibits cprk activity. Cdk5/p35 may therefore regulate cprk function in the brain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12832520      PMCID: PMC6741199     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  82 in total

1.  Interaction of neuronal Cdc2-like protein kinase with microtubule-associated protein tau.

Authors:  K Sobue; A Agarwal-Mawal; W Li; W Sun; Y Miura; H K Paudel
Journal:  J Biol Chem       Date:  2000-06-02       Impact factor: 5.157

2.  Immunohistochemical localization of CDK5 activator p39 in the rat brain.

Authors:  Y Honjyo; Y Kawamoto; S Nakamura; S Nakano; I Akiguchi
Journal:  Neuroreport       Date:  1999-11-08       Impact factor: 1.837

3.  Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5.

Authors:  M K Ahlijanian; N X Barrezueta; R D Williams; A Jakowski; K P Kowsz; S McCarthy; T Coskran; A Carlo; P A Seymour; J E Burkhardt; R B Nelson; J D McNeish
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

4.  Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25.

Authors:  G Kusakawa; T Saito; R Onuki; K Ishiguro; T Kishimoto; S Hisanaga
Journal:  J Biol Chem       Date:  2000-06-02       Impact factor: 5.157

5.  CDK-5-mediated neurofilament phosphorylation in SHSY5Y human neuroblastoma cells.

Authors:  M Sharma; P Sharma; H C Pant
Journal:  J Neurochem       Date:  1999-07       Impact factor: 5.372

6.  Migration defects of cdk5(-/-) neurons in the developing cerebellum is cell autonomous.

Authors:  T Ohshima; E C Gilmore; G Longenecker; D M Jacobowitz; R O Brady; K Herrup; A B Kulkarni
Journal:  J Neurosci       Date:  1999-07-15       Impact factor: 6.167

7.  Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons.

Authors:  J A Bibb; G L Snyder; A Nishi; Z Yan; L Meijer; A A Fienberg; L H Tsai; Y T Kwon; J A Girault; A J Czernik; R L Huganir; H C Hemmings; A C Nairn; P Greengard
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

8.  Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration.

Authors:  G N Patrick; L Zukerberg; M Nikolic; S de la Monte; P Dikkes; L H Tsai
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

9.  Phosphorylation of neurofilament heavy chain side-arms by stress activated protein kinase-1b/Jun N-terminal kinase-3.

Authors:  J Brownlees; A Yates; N P Bajaj; D Davis; B H Anderton; P N Leigh; C E Shaw; C C Miller
Journal:  J Cell Sci       Date:  2000-02       Impact factor: 5.285

10.  p39 activates cdk5 in neurons, and is associated with the actin cytoskeleton.

Authors:  S Humbert; R Dhavan; L Tsai
Journal:  J Cell Sci       Date:  2000-03       Impact factor: 5.285

View more
  28 in total

1.  Special Issue on "Cdk5 and Brain Disorders": Prologue.

Authors:  Jyotshnabala Kanungo
Journal:  Brain Disord Ther       Date:  2012-05-31

2.  A SNP in OsMCA1 responding for a plant architecture defect by deactivation of bioactive GA in rice.

Authors:  Zhenwei Liu; Qin Cheng; Yunfang Sun; Huixia Dai; Gaoyuan Song; Zhibin Guo; Xuefeng Qu; Daiming Jiang; Chuan Liu; Wei Wang; Daichang Yang
Journal:  Plant Mol Biol       Date:  2014-10-12       Impact factor: 4.076

3.  Azoospermia in mice with targeted disruption of the Brek/Lmtk2 (brain-enriched kinase/lemur tyrosine kinase 2) gene.

Authors:  Seiji Kawa; Chizuru Ito; Yoshiro Toyama; Mamiko Maekawa; Tohru Tezuka; Takahisa Nakamura; Takanobu Nakazawa; Kazumasa Yokoyama; Nobuaki Yoshida; Kiyotaka Toshimori; Tadashi Yamamoto
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-08       Impact factor: 11.205

4.  Cyclin-dependent kinase 5 phosphorylation of human septin SEPT5 (hCDCrel-1) modulates exocytosis.

Authors:  Niranjana D Amin; Ya-Li Zheng; Sashi Kesavapany; Jyotshnabala Kanungo; Tad Guszczynski; Ram K Sihag; Parvathi Rudrabhatla; Wayne Albers; Philip Grant; Harish C Pant
Journal:  J Neurosci       Date:  2008-04-02       Impact factor: 6.167

5.  Phosphorylation of AATYK1 by Cdk5 suppresses its tyrosine phosphorylation.

Authors:  Koji Tsutsumi; Tetsuya Takano; Ryo Endo; Mitsunori Fukuda; Toshio Ohshima; Mineko Tomomura; Shin-ichi Hisanaga
Journal:  PLoS One       Date:  2010-04-20       Impact factor: 3.240

6.  Alterations in LMTK2, MSMB and HNF1B gene expression are associated with the development of prostate cancer.

Authors:  Lorna W Harries; John R B Perry; Paul McCullagh; Malcolm Crundwell
Journal:  BMC Cancer       Date:  2010-06-22       Impact factor: 4.430

7.  Apoptosis-associated tyrosine kinase and neuronal cell death.

Authors:  Jane P Hughes; Daniel R Ward; Laura Facci; Jill C Richardson; Stephen D Skaper
Journal:  Neurochem Res       Date:  2009-11-26       Impact factor: 3.996

8.  Targeting Cdk5 activity in neuronal degeneration and regeneration.

Authors:  Jyotshnabala Kanungo; Ya-li Zheng; Niranjana D Amin; Harish C Pant
Journal:  Cell Mol Neurobiol       Date:  2009-12       Impact factor: 5.046

9.  Actin interaction and regulation of cyclin-dependent kinase 5/p35 complex activity.

Authors:  Jiqing Xu; Koji Tsutsumi; Kiyotaka Tokuraku; Katherine A Estes; Shin-ichi Hisanaga; Tsuneya Ikezu
Journal:  J Neurochem       Date:  2011-01       Impact factor: 5.372

10.  p35/Cyclin-dependent kinase 5 is required for protection against beta-amyloid-induced cell death but not tau phosphorylation by ceramide.

Authors:  Kathleen I Seyb; Sabah Ansar; Guibin Li; Jennifer Bean; Mary L Michaelis; Rick T Dobrowsky
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.